The Impact of the Different Market Factors on Synthetic Biology Market


Posted June 14, 2018 by akshayjadhav

The global synthetic biology market was valued at USD 3.02 Billion in 2016 and is expected to grow at a CAGR of 19.9% during the forecast period to reach to USD 8.84 Billion by 2022.

 
Synthetic Biology Market by Tool (Oligonucleotides, Chassis Organisms, Enzymes), Technology (Genome Engineering, NGS, Cloning and Sequencing), Application (Medical (Pharmaceutical, Drug Discovery), Industrial (Renewable Energy)) - Global Forecast to 2022
The global synthetic biology market was valued at USD 3.02 Billion in 2016 and is expected to grow at a CAGR of 19.9% during the forecast period to reach to USD 8.84 Billion by 2022. The base year considered for the study is 2016 and the forecast for the market size is provided for the period between 2017 and 2022.

Objectives of the Study

To define, describe, and forecast the global market by tools, technologies, applications, and region
To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
To forecast the size of market segments with respect to four main regions, namely, North America, Europe, Asia Pacific, and the Rest of the World
To profile key players and comprehensively analyze their core competencies in terms of key market developments, product portfolios, and financials
To track and analyze competitive developments such as collaborations, partnerships, and agreements; expansions; product launches; acquisitions; and other developments in the synthetic biology market
Research Methodology

Top-down and bottom-up approaches were used to validate the size of the synthetic biology market and estimate the size of other dependent submarkets. Various secondary sources such as Centre for Synthetic Biology and Innovation (CSynBI), Institute of Systems and Synthetic Biology, University of California San Francisco (UCSF) Center for Systems & Synthetic Biology, Synthetic Biology Leadership Council (SBLC), Synthetic Biology Advisory Committee, Synthetic Biology Engineering Research Center (SynBERC), Industry Association of Synthetic Biology (IASB), European association of synthetic biology, Society for Biological Engineering (SBE), Systems and Synthetic Biology Journal, Biological Sciences Research Council, expert interviews, and MarketsandMarkets Analysishave been used to identify and collect information useful for the study of this market. Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as well as to assess dynamics of this market. The breakdown of profiles of primaries is shown in the figure below:

To know about the assumptions considered for the study, download the pdf brochure

This high growth rate can be attributed to the wide range of applications of synthetic biology, rising R&D funding and initiatives, increasing demand for synthetic genes and synthetic cells, and increasing investments in synthetic biology companies. Factors such as rising concerns regarding fuel consumption and increasing demand for protein therapeutics are expected to offer lucrative opportunities for players in the global market.

In this report, the global synthetic biology market is segmented on the basis of tool, technology, application, and region. Based on tools, the market is segmented into oligonucleotides, enzymes, cloning technology kits, chassis organisms, and xeno-nucleic acids. In 2017, oligonucleotides are expected to account for the largest share of the global market owing to the large-scale production of modified oligonucleotides for next-generation sequencing and the increasing market demand for synthetic genes.

By technology, the synthetic biology market is segmented into gene synthesis, genome engineering, cloning and sequencing, next-generation sequencing, site-directed mutagenesis, measurement and modeling, microfluidics, and nanotechnology. In 2017, the gene synthesis segment is expected to account for the largest share of the global market in technology. This is attributed to the fact that the technology is used in a wide range of applications such as producing vaccines, engineering enzymes to restrict cancer growth, producing sustainable biofuels, improving crop yield, and detecting and breaking down environmental pollutants in the soil, air, and water offered by gene synthesis.

The synthetic biology market is segmented into medical (pharmaceutical, drug discovery & therapeutics, and artificial tissue and tissue regeneration), industrial (biofuel & renewable energy, industrial enzymes, and biomaterials & green chemicals), food & agriculture, and environmental (bioremediation and biosensing) on the basis of application. The pharmaceuticals subsegment is expected to account for the largest share of the market. However, biofuel and renewable energy is expected to grow at the highest CAGR during the forecast period owing to the global demand for fossil fuel alternatives and the advantages of the genetically engineered organisms for the synthetic production of biofuels

Based on region, the synthetic biology market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2017, North America is estimated to account for the largest share of the global market. Regarding growth rate, Europe is expected to register the highest growth rate from 2017 to 2022. Factors such as increasing investments for the adoption of adoption of novel synthetic biology technologies, rising R&D funding and collaborations are driving the growth of the market in this region.

While the overall market is expected to grow at a high rate, possible environmental and security issues related to synthetic biology is likely to restrain the growth of this market to a certain extent.

The major players in the global synthetic biology market include Thermo Fisher (US), Novozymes (Denmark), Merck KGaA (Germany), Intrexon (US), and Agilent Technologies (US), among others.
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By marketsandmarkets
Website The Impact of the Different Market Factors on Synthetic Biology Market
Country India
Categories Government , Health , Medical
Tags synthetic biology market
Last Updated June 14, 2018